199 related articles for article (PubMed ID: 34826787)
1. Identifying barriers to emergency department-initiated buprenorphine: A spatial analysis of treatment facility access in Michigan.
Dora-Laskey A; King A; Sadler R
Am J Emerg Med; 2022 Jan; 51():393-396. PubMed ID: 34826787
[TBL] [Abstract][Full Text] [Related]
2. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
[TBL] [Abstract][Full Text] [Related]
3. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers.
Hu T; Snider-Adler M; Nijmeh L; Pyle A
CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398
[TBL] [Abstract][Full Text] [Related]
5. Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.
Chua KP; Dahlem CHY; Nguyen TD; Brummett CM; Conti RM; Bohnert AS; Dora-Laskey AD; Kocher KE
Ann Emerg Med; 2022 Mar; 79(3):225-236. PubMed ID: 34802772
[TBL] [Abstract][Full Text] [Related]
6. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.
Goedel WC; Shapiro A; Cerdá M; Tsai JW; Hadland SE; Marshall BDL
JAMA Netw Open; 2020 Apr; 3(4):e203711. PubMed ID: 32320038
[TBL] [Abstract][Full Text] [Related]
7. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
[TBL] [Abstract][Full Text] [Related]
8. Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation.
Belden C; Kopak A; Coules C; Friesen T; Hall J; Shukla S
J Subst Use Addict Treat; 2024 Jul; 162():209364. PubMed ID: 38626851
[TBL] [Abstract][Full Text] [Related]
9. The use of buprenorphine to-go packs in the emergency department.
Zimmerman DE; Johnson B; Kearns A; Metro H; Robb A; Nemecek BD; Montepara CA; Covvey JR; Lynch MJ
Am J Emerg Med; 2024 Mar; 77():154-157. PubMed ID: 38150985
[TBL] [Abstract][Full Text] [Related]
10. Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation.
Sun T; Aroke H; Kogut S; Katenka N; Bratberg J; Buchanan A
Am J Drug Alcohol Abuse; 2022 Mar; 48(2):217-225. PubMed ID: 34780312
[No Abstract] [Full Text] [Related]
11. Sustained Implementation of a Multicomponent Strategy to Increase Emergency Department-Initiated Interventions for Opioid Use Disorder.
Lowenstein M; Perrone J; Xiong RA; Snider CK; O'Donnell N; Hermann D; Rosin R; Dees J; McFadden R; Khatri U; Meisel ZF; Mitra N; Delgado MK
Ann Emerg Med; 2022 Mar; 79(3):237-248. PubMed ID: 34922776
[TBL] [Abstract][Full Text] [Related]
12. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
[TBL] [Abstract][Full Text] [Related]
13. Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.
Fox L; Nelson LS
CNS Drugs; 2019 Dec; 33(12):1147-1154. PubMed ID: 31552608
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
[TBL] [Abstract][Full Text] [Related]
15. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
D'Onofrio G; O'Connor PG; Pantalon MV; Chawarski MC; Busch SH; Owens PH; Bernstein SL; Fiellin DA
JAMA; 2015 Apr; 313(16):1636-44. PubMed ID: 25919527
[TBL] [Abstract][Full Text] [Related]
16. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder.
Cowan E; Perrone J; Bernstein SL; Coupet E; Fiellin DA; Hawk K; Herring A; Huntley K; McCormack R; Venkatesh A; D'Onofrio G
Ann Emerg Med; 2023 Sep; 82(3):326-335. PubMed ID: 37178101
[TBL] [Abstract][Full Text] [Related]
17. Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
Davis CS; Carr DH; Glenn MJ; Samuels EA
Ann Emerg Med; 2021 Jul; 78(1):102-108. PubMed ID: 33781607
[TBL] [Abstract][Full Text] [Related]
18. Where Opioid Overdose Patients Live Far From Treatment: Geospatial Analysis of Underserved Populations in New York State.
Abell-Hart K; Rashidian S; Teng D; Rosenthal RN; Wang F
JMIR Public Health Surveill; 2022 Apr; 8(4):e32133. PubMed ID: 35412467
[TBL] [Abstract][Full Text] [Related]
19. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
[TBL] [Abstract][Full Text] [Related]
20. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]